Last reviewed · How we verify

NCT05678829

Reproductive Health and Family Planning

Status unknown NA Last updated 12 January 2023
What this trial tests

NA trial testing Education in Virtual Reality in 130 participants. Status unknown.

Timeline
15 July 2022
Primary endpoint
30 April 2023
15 June 2023

Quick facts

Lead sponsorSümeyye Betül SÖNMEZ
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment130
Start date15 July 2022
Primary completion30 April 2023
Estimated completion15 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sümeyye Betül SÖNMEZ

Who can join

18 and older, female only, with Virtual Reality or Reproductive Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to measure the knowledge and attitude levels of women who play a key role in society on reproductive health and family planning, and to determine the changes in their attitudes and behaviors after face-to-face training with virtual reality application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of Virtual Reality in Reproductive Health and Family Planning Education: A Randomized Controlled Trial: A Different Method In Reproductive Health And Family Planning Education: Virtual Reality.
    Sönmez SB, Türkoğlu N. · · 2026 · PMID 41677032 · DOI 10.1111/phn.70082

Verify or expand the search:

Other trials of Education

Trials testing the same drug.

Other recruiting trials for Virtual Reality

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05678829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing